Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

PurposeThe aim of this study was to assess the prognostic influence of Ki67 index changes in patients with primary triple-negative breast cancer (TNBC) treated with neoadjuvant chemotherapy (NAC), and to evaluate whether the combination of Ki67 index changes and residual disease (RD) tumor-infiltrat...

Full description

Bibliographic Details
Main Authors: Yihua Wang, Beige Zong, Yu Yu, Yu Wang, Zhenrong Tang, Rui Chen, Man Huang, Shengchun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Oncology
Subjects:
triple-negative breast cancer
Ki67
tumor-infiltrating lymphocytes
neoadjuvant chemotherapy
residual disease
prognostic factor
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.668610/full

Similar Items

Similar Items